This post is part of our Q&A series.
A question from graduate students in our Fall 2019 offering of “Biostatistical Methods: Survival Analysis and Causality” at UC Berkeley:
Question:
Hi Mark,
We are wondering under your framework, how to deal with a situation when only right-censored data has a full set of covariates, while the covariates for the non-right-censored data are largely missing. To be specific, we want to find the relation between peoples’ matching property and their marriage durations.

This post is part of our Q&A series.
A question from graduate students in our Fall 2019 offering of “Biostatistical Methods: Survival Analysis and Causality” at UC Berkeley:
Question:
Hi Mark,
We were wondering about the application of TMLE and superlearner to cluster-randomized study designs, and the adoption of the sample average treatment effect (SATE) as an efficient estimator. From our understanding, although the SATE is not formally identifiable in a finite setting, it is nevertheless an efficient estimate due to its asymptotic behavior (TMLE for the population effect is asymptotically linear and has an asymptotically conservative variance estimator).

This post is part of our Q&A series.
A question from graduate students in our Fall 2019 offering of “Biostatistical Methods: Survival Analysis and Causality” at UC Berkeley:
Question:
Hi Mark,
Suppose we have a longitudinal data structure where information about the intervention and time-varying covariate is collected simultaneously, and their temporal ordering is obscured. For instance, data is collected at monthly health checkups, where $A(t)$ is the subject’s healthy eating habits in the past month, and $L(t)$ is the occurrence of heartburn in the past month.

This post is part of our Q&A series.
A question from graduate students in our Fall 2019 offering of “Biostatistical Methods: Survival Analysis and Causality” at UC Berkeley:
Question:
Hi Mark,
For longitudinal data such as $O=(L_0,A_0,Y_0,L_1,A_1,Y_1,L_2,A_2,Y_2,\ldots )$, we can use G-computation formula with sequential regression method if we treat time $t$ as discrete variable. And you also mentioned that there are more general methods which can deal with the case when $t$ is continuous.

This post is part of our Q&A series.
A question from graduate students in our Fall 2019 offering of “Biostatistical Methods: Survival Analysis and Causality” at UC Berkeley:
Question:
Hi Mark,
First of all, I have doubts regarding the simultaneous confidence interval for Kaplan- Meier, since I am not necessarily interested in inference for a parameter. I would like > to know if the 95% confidence band for my KM estimator will hold using the same formula > we did in our R lab without covariates (taken from lectures).

This post is part of our Q&A series.
A question from Twitter on choosing between double machine learning and TMLE with cross-validation: https://twitter.com/emaadmanzoor/status/1208924841316880385
Question:
@mark_vdlaan Is there an applied researcher’s guide to choosing between double machine learning and TMLE + cross-fitting? PS: Thanks for making these methods and resources so easily accessible!
Answer:
Thanks for this interesting question. In the past several years, the interest in these machine learning-based estimators has become more widespread, since they allow for the statistical answer to a question to be framed in terms of scientifically meaningful parameters (e.

This post is part of our Q&A series.
A question from graduate students in our Spring 2019 offering of “Targeted Learning in Biomedical Big Data” at Berkeley:
Question:
Hi Mark,
We are curious about how to use TMLE and influence curves for estimation and inference when the target parameter is a conditional expectation, rather than a scalar.
Specifically, suppose I have a data structure $O = (W, Y) \sim P_0$, and sample $n$ times i.

This post is part of our Q&A series.
A question from graduate students in our Spring 2019 offering of “Targeted Learning in Biomedical Big Data” at Berkeley:
Question:
Hi Mark,
Thanks for teaching this class. It’s been an amazing experience. I have a few questions related to my own research.
In infectious disease studies, modeling attempts to create models that estimate protection conferred from vaccination or previous history of infection (natural immunity).

This post is part of our Q&A series.
A question from graduate students in our Spring 2019 offering of “Targeted Learning in Biomedical Big Data” at Berkeley:
Question:
Hi Mark,
A couple questions I have are about super learning and the strength of the learners as well as potentially adaptively choosing learners. Is there any advantage, theoretical or practical, of having a large library of weaker learners over a small library of stronger learners?

This post is part of our Q&A series.
A question from graduate students in our Spring 2019 offering of “Targeted Learning in Biomedical Big Data” at Berkeley:
Question:
Hi Mark,
Is there any theoretical guarantees about relative performances between TMLE and the one-step estimator in finite sample conditions?
Thanks.
H. R.d.B.
Answer:
Hi H. R.d.B.,
Finite sample guarantees are very hard to obtain. One can obtain finite-sample confidence intervals by, for example, not relying on a CLT but on finite-sample inequalities for sample means (e.

This post is part of our Q&A series.
A question from graduate students in our Spring 2019 offering of “Targeted Learning in Biomedical Big Data” at Berkeley:
Question:
Hi Mark,
For a longitudinal data set if we have missing data, we might want to impute the values with MICE imputation (multiple imputation with chain equations). Can we use TMLE together with multiple imputation? How can we combine the results of all the multiple imputed datasets into a final result and obtain valid inference?

This post is part of our Q&A series.
A question from graduate students in our Fall 2018 offering of “Special Topics in Biostatistics – Adaptive Designs” at Berkeley:
Question:
Hi Mark,
We were interested in your opinion on few topics that have come up in class a few times.
If we isolate an optimal subgroup, we can, perhaps, answer interesting questions about, say, drug efficacy (as in, does this drug work for anybody as opposed to on average?

This post is part of our Q&A series.
A question from graduate students in our Fall 2018 offering of “Special Topics in Biostatistics – Adaptive Designs” at Berkeley:
Question:
Hi Mark,
Our question concerns the benefit of using a sequential adaptive design when estimating the outcome under the optimal dynamic treatment rule (for a binary treatment). We propose doing so in a 2-stage framework, where in the first stage subjects are naively randomized to treatment, $Pr(A=1) = 0.

This post is part of our Q&A series.
A question from a graduate student in our Spring 2018 offering of “Targeted Learning in Biomedical Big Data” at Berkeley:
Question:
Hi Mark,
I was thinking that if you addressed the question that [we] discussed in your office hours last week, a lot of economists would be interested in reading it.
Feel free to edit the wording of the question however suits you best, but I was thinking: How can you formulate a causal parameter in a setting in which you have a policy that affects one group but not another based on observable characteristics and control for time trends in your model (i.

This post is part of our Q&A series.
A question from a graduate student in our Fall 2017 offering of “Survival Analysis and Causality” at Berkeley:
Question:
Hi Mark,
This may be an ill-defined question, but I was wondering, in the usual $O = (W, A, Y)$ set-up, while TMLE has superior asymptotic properties over competing estimators like, say, the G-computation plug-in estimator or the IPTW estimator, are there specific instances where it is also guaranteed to have superior finite sample properties as well?

This post is part of our Q&A series.
A question from two graduate students in our Fall 2017 offering of “Survival Analysis and Causality” at Berkeley:
Question:
Hi Mark,
Below are [two] questions [we thought might interest you]. Looking forward to your thoughts on these!
Best, S.D. and I.M.
Most competing risk analyses assume that the competing risks are independent of one another. What would be your advice on handling the same style of survival data when the occurrence of one of the competing events is informative of the occurrence of the other?

This post is part of our Q&A series.
A question from two graduate students in our Fall 2017 offering of “Survival Analysis and Causality” at Berkeley:
Question:
Hi Mark,
[We] were wondering what the implications were for selecting leave one observation out versus leave one cluster out when performing cross-validation on a longitudinal data structure. We understand that computational constraints may render leave-one-out cross-validation to be undesirable, however are we implicitly biasing our model selection by our choice in cross-validation technique?

Welcome! This is the research blog of Mark van der Laan.
Over the last few years, communication in science has evolved; indeed, many exciting and inspiring research-related ideas are now first communicated informally, with blog posts and the like, before formal publication in academic journals. Blog posts provide an excellent medium through which interesting ideas can be communicated quickly and concisely. We plan to use this blog to share ideas, tips, and examples from our research – and to establish an open dialogue with researchers around the world.